Home

kaas gebonden ademen teva news Geef rechten Drijvende kracht ondergoed

Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ

Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury  finds - JURIST - News
Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News

San Francisco reaches $58m opioid settlement with Teva, Allergan | Drugs  News | Al Jazeera
San Francisco reaches $58m opioid settlement with Teva, Allergan | Drugs News | Al Jazeera

The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech

Teva Pharmaceuticals Soars After Buffett's Berkshire Hathaway Discloses  Stake
Teva Pharmaceuticals Soars After Buffett's Berkshire Hathaway Discloses Stake

Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe |  Stock News & Stock Market Analysis - IBD
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD

New York AG: Teva USA's parent company shouldn't be allowed to escape  opioid liability - MedCity News
New York AG: Teva USA's parent company shouldn't be allowed to escape opioid liability - MedCity News

Buy Teva Pharmaceuticals amid positive news, Bernstein says
Buy Teva Pharmaceuticals amid positive news, Bernstein says

Teva CEO Schultz likely won't renew employment contract: reports
Teva CEO Schultz likely won't renew employment contract: reports

Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's

Teva looks to amp up research collaborations, CEO says
Teva looks to amp up research collaborations, CEO says

Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News

Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State

Teva made smart decision to move to us: Allergan CEO
Teva made smart decision to move to us: Allergan CEO

Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals is found liable in the opioid crisis : NPR

Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news  conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a  40 percent jump in quarterly profit that beat estimates,
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,

Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to  hold shareholder vote
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote

New York could get $524M under opioid settlements with Teva - ABC News
New York could get $524M under opioid settlements with Teva - ABC News

Teva_Pharmaceuticals | ערוץ 7
Teva_Pharmaceuticals | ערוץ 7

Allergan to own 10% stake in Teva
Allergan to own 10% stake in Teva

Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill

Teva shares surge after announcing global opioid settlement
Teva shares surge after announcing global opioid settlement

Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceuticals found liable in New York opioid trial - BBC News

Marksans Pharma acquires Teva's manufacturing site in Goa - The Economic  Times
Marksans Pharma acquires Teva's manufacturing site in Goa - The Economic Times

Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Pharmaceuticals (@TevaUSA) / Twitter

Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of  Israel
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel

Teva Pharmaceuticals USA found liable in opioids case - Newsday
Teva Pharmaceuticals USA found liable in opioids case - Newsday